Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Artificial Intelligence Enabled System for Retinal Nerve Fiber Layer Thickness Damage Severity Staging.

Ophthalmology science·2023
Same author

Detecting glaucoma from multi-modal data using probabilistic deep learning.

Frontiers in medicine·2022
Same author

Use of an automatic refractometer as a screening tool for pigment dispersion syndrome detection.

Survey of ophthalmology·2022
Same author

It Is All about Pressure.

Journal of clinical medicine·2022
Same author

Editorial: Glaucoma and Brain: Impact of Neurodegeneration on Visual Abilities and Related Biomarkers.

Frontiers in aging neuroscience·2022
Same author

Canaloplasty in Pseudoexfoliation Glaucoma. Can It Still Be Considered a Good Choice?

Journal of clinical medicine·2022

Related Experiment Video

Updated: May 16, 2026

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
07:30

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction

Published on: October 13, 2017

Canaloplasty after failed trabeculectomy: a possible option.

Paolo Brusini1, Claudia Tosoni

  • 1S. Maria della Misericordia Hospital, Udine, Italy.

Journal of Glaucoma
|December 11, 2012
PubMed
Summary

Canaloplasty can effectively lower intraocular pressure (IOP) in patients with glaucoma who have previously failed trabeculectomy surgery. This procedure offers a viable alternative for managing refractory glaucoma when Schlemm's canal remains undamaged.

Related Experiment Videos

Last Updated: May 16, 2026

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
07:30

Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction

Published on: October 13, 2017

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Microsurgery

Background:

  • Canaloplasty is typically performed on eyes without prior filtering surgery for glaucoma.
  • Trabeculectomy may spare Schlemm's canal, making it amenable to subsequent canaloplasty.
  • Elevated intraocular pressure (IOP) despite maximal medical therapy necessitates alternative treatments.

Purpose of the Study:

  • To evaluate the efficacy and safety of canaloplasty in patients with previously failed trabeculectomy.
  • To assess IOP reduction and medication usage after canaloplasty in this specific patient group.

Main Methods:

  • Retrospective analysis of 6 eyes undergoing canaloplasty after failed trabeculectomy.
  • Preoperative and postoperative IOP measurements and medication counts were recorded.
  • Surgical outcomes, including successful cannulation and conversion to viscocanalostomy, were documented.

Main Results:

  • Canaloplasty was successfully completed in 5 out of 6 eyes.
  • Mean preoperative IOP of 32.2±9.6 mm Hg decreased significantly postoperatively.
  • Mean IOP at 24 months was 16.3 mm Hg, with a reduction in medication use from 3.2 to 2.3.

Conclusions:

  • Canaloplasty is a potential surgical option for eyes with failed trabeculectomy, provided Schlemm's canal is intact.
  • The procedure demonstrates significant IOP-lowering effects and reduces medication dependency in selected glaucoma patients.